piribedil has been researched along with Dyskinesia Syndromes in 10 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Side effects (hallucinations, confusion, dyskinesias) were frequent, but were usually reversible by lowering the dosage of levodopa or the accompanying anticholinergic medication." | 1.26 | Piribedil: its synergistic effect in multidrug regimens for parkinsonism. ( Feigenson, JS; McDowell, FH; Sweet, RD, 1976) |
| " The main metabolite of piribedil, S 584, had no clear-cut pharmacologic action in our hands at the dosage used." | 1.25 | Apomorphine and piribedil in rats: biochemical and pharmacologic studies. ( Barbeau, A; Butterworth, RF; Poignant, JC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parkes, JD | 1 |
| Lieberman, AN | 1 |
| Shopsin, B | 1 |
| Brun, YL | 1 |
| Boal, D | 1 |
| Zolfaghari, M | 1 |
| Goldstein, M | 1 |
| Battista, AF | 1 |
| Miyamoto, T | 1 |
| Cools, AR | 1 |
| Van Rossum, JM | 1 |
| Engel, J | 1 |
| Granerus, AK | 1 |
| Svanborg, A | 1 |
| Agnoli, A | 2 |
| Feigenson, JS | 1 |
| Sweet, RD | 1 |
| McDowell, FH | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Butterworth, RF | 1 |
| Poignant, JC | 1 |
| Barbeau, A | 1 |
| Meco, G | 1 |
| Ruggieri, S | 1 |
| Carolei, A | 1 |
| Cerbo, R | 1 |
| Zamponi, A | 1 |
1 review available for piribedil and Dyskinesia Syndromes
| Article | Year |
|---|---|
Bromocriptine in the treatment of parkinsonism.
Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Ac | 1979 |
1 trial available for piribedil and Dyskinesia Syndromes
| Article | Year |
|---|---|
Studies on piribedil in Parkinsonism.
Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Humans; Huntington Disease; Mental Disorders | 1975 |
8 other studies available for piribedil and Dyskinesia Syndromes
| Article | Year |
|---|---|
Modification of involuntary movements by centrally acting drugs.
Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhin | 1975 |
Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.
Topics: Amphetamines; Animals; Apomorphine; Brain; Cats; Caudate Nucleus; Corpus Striatum; Dopamine; Electro | 1976 |
Piribedil in Parkinson's syndrome: a clinical study.
Topics: Activities of Daily Living; Aged; Alkaline Phosphatase; Brain Diseases; Dose-Response Relationship, | 1975 |
[Problems in the long-term medical treatment of sequelae of acute cerebrovascular diseases. Double-blind studies].
Topics: Cerebrovascular Disorders; Cognition Disorders; Emotions; Headache; Humans; Mental Processes; Motor | 1976 |
Piribedil: its synergistic effect in multidrug regimens for parkinsonism.
Topics: Aged; Amantadine; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Methyld | 1976 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Anta | 1975 |
Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
Topics: Amygdala; Animals; Apomorphine; Behavior; Brain; Corpus Striatum; Drug Synergism; Hippocampus; Human | 1975 |
[Animal stereotypy and transmethylation of cerebral amines].
Topics: Amines; Amphetamine; Animals; Apomorphine; Brain; Levodopa; Movement Disorders; Piribedil; Rats; S-A | 1975 |